Process Validation of Escitalopram oxalate 5 mg Tablet

Priyanka Upadhyay; Rupesh Pandey; R.K. Pothal

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Process Validation of Escitalopram oxalate 5 mg Tablet

Author(s): Priyanka Upadhyay, Rupesh Pandey, R.K. Pothal

Email(s): priya_231137@yahoo.in

DOI: Not Available

Address: Priyanka Upadhyay1, Rupesh Pandey2 and R.K. Pothal2
1Gayatri College of Pharmacy Rourkela Orissa
2Vivikanand College of Pharmacy, Indore (M.P.)
*Corresponding Author

Published In: Volume - 6, Issue - 4, Year - 2013

View HTML

View PDF

ABSTRACT:
Effective process validation contributes significantly to assuring drug quality. Process Validation of Escitalopram oxalate Tablet 5 mg strength was developed for the quality control and quality assurance purpose. In Vitro dissolution study was carried out using USP II apparatus (paddle apparatus). The crushing strength Kg/cm2 of prepared tablets was determined for 10 tablets of and standard deviation was determined for each batch. The average hardness and standard deviation was studied. Assay was performed to know the content of drug substance by UV spectrophotometer. The Method was validated in accordance to ICH guidelines.

Keywords:

Process Validation of Escitalopram oxalate 5 mg Tablet.

Cite this article:
Priyanka Upadhyay, Rupesh Pandey, R.K. Pothal. Process Validation of Escitalopram oxalate 5 mg Tablet. Research J. Pharm. and Tech. 6(4): April 2013; Page 422-427.

Cite(Electronic):
Priyanka Upadhyay, Rupesh Pandey, R.K. Pothal. Process Validation of Escitalopram oxalate 5 mg Tablet. Research J. Pharm. and Tech. 6(4): April 2013; Page 422-427. Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2013-6-4-11